— Know what they know.
Not Investment Advice

ARDX NASDAQ

Ardelyx, Inc.
1W: -1.7% 1M: +5.5% 3M: +10.8% YTD: +3.2% 1Y: +51.9% 3Y: +42.4% 5Y: +273.5%
$6.11
-0.24 (-3.78%)
 
Weekly Expected Move ±7.7%
$5 $6 $6 $7 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 53 · $1.5B mcap · 236M float · 1.60% daily turnover · Short 48% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
54.9 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -26.0%  ·  5Y Avg: 44.6%
Cost Advantage
59
Intangibles
55
Switching Cost
55
Network Effect
82
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ARDX shows a Weak competitive edge (54.9/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -26.0% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$0
Low
$17
Avg Target
$17
High
Based on 9 analyst ratings (12 mo)
Analyst Recommendations
Strong Buy: 0Buy: 16Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$17.00
Analysts1
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-03-12 Williams Trading Roanna Ruiz Initiated $17 +200.4% $5.66
2026-02-20 H.C. Wainwright $11 $18 +7 +167.1% $6.74
2026-01-27 Jefferies $8 $15 +7 +92.3% $7.80
2026-01-09 BTIG Julian Harrison $14 $17 +3 +142.9% $7.00
2026-01-08 Piper Sandler $10 $16 +6 +128.6% $7.00
2026-01-08 Raymond James Christopher Raymond $15 $19 +4 +171.6% $7.00
2025-11-04 Piper Sandler Initiated $10 +70.6% $5.86
2025-08-05 Wedbush $2 $14 +12 +172.9% $5.13
2025-08-05 UBS Initiated $12 +133.9% $5.13
2025-03-04 BTIG Initiated $14 +158.8% $5.41
2025-01-02 Jefferies Dennis Ding Initiated $8 +56.2% $5.12
2024-08-05 H.C. Wainwright Ed Arce $10 $11 +1 +81.8% $6.05
2024-07-05 H.C. Wainwright Ed Arce Initiated $10 +89.0% $5.29
2024-05-24 Raymond James Christopher Raymond $12 $15 +3 +108.3% $7.20
2023-12-18 Raymond James Ryan Deschner Initiated $12 +90.3% $6.30
2022-12-29 Citigroup Initiated $7 +145.6% $2.85
2022-12-29 Wedbush Laura Chico Initiated $2 -14.3% $2.33

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
May 22, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ARDX receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

25 Grade D
Profitability
20
Balance Sheet
57
Earnings Quality
56
Growth
59
Value
29
Momentum
56
Safety
30
Cash Flow
30
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ARDX scores highest in Growth (59/100) and lowest in Profitability (20/100). A grade of D flags significant fundamental concerns across multiple dimensions.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
1.32
Distress Zone
Piotroski F-Score
4/9
Beneish M-Score
-2.36
Unlikely Manipulator
Ohlson O-Score
-5.49
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
BB-
Score: 37.9/100
Trend: Deteriorating
Earnings Quality
OCF/NI: 0.62x
Accruals: -4.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ARDX scores 1.32, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ARDX scores 4/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ARDX's score of -2.36 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ARDX's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ARDX receives an estimated rating of BB- (score: 37.9/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-25.87x
PEG
2.44x
P/S
3.53x
P/B
10.11x
P/FCF
-39.27x
P/OCF
EV/EBITDA
-44.51x
EV/Revenue
3.32x
EV/EBIT
-40.25x
EV/FCF
-37.86x
Earnings Yield
-3.94%
FCF Yield
-2.55%
Shareholder Yield
0.00%
Graham Number
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. ARDX currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.002
NI / EBT
×
Interest Burden
1.643
EBT / EBIT
×
EBIT Margin
-0.082
EBIT / Rev
×
Asset Turnover
0.913
Rev / Assets
×
Equity Multiplier
2.755
Assets / Equity
=
ROE
-34.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ARDX's ROE of -34.1% is driven by Asset Turnover (0.913), indicating efficient use of assets to generate revenue. A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
Price/Value
Margin of Safety
Premium
Assessment
Overvalued

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$6.11
Median 1Y
$5.99
5th Pctile
$1.64
95th Pctile
$21.80
Ann. Volatility
80.1%
Analyst Target
$17.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Michael Raab President,
Chief Executive Officer and Director
$797,000 $2,953,724 $7,796,171
Edward Conner, M.D.
Former Chief Medical Officer
$213,019 $1,574,775 $3,623,910
Justin Renz Financial
ief Financial and Operations Officer
$464,434 $1,578,559 $3,551,684
Susan Hohenleitner Financial
ancial Officer
$120,929 $735,949 $3,437,372
John Bishop, Ph.D.
Chief Technical and Quality Officer
$240,000 $1,004,980 $2,512,522
Elizabeth Grammer, Esq.
Former Chief Legal and Administrative Officer
$527,126 $708,002 $2,303,617

CEO Pay Ratio

11:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $7,796,171
Avg Employee Cost (SGA/emp): $689,638
Employees: 489

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
489
+23.8% YoY
Revenue / Employee
$832,965
Rev: $407,320,000
Profit / Employee
$-125,969
NI: $-61,599,000
SGA / Employee
$689,638
Avg labor cost proxy
R&D / Employee
$146,272
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE -80.1% -96.4% -1.5% -1.5% -1.3% -1.1% -74.3% -72.8% -62.0% -29.4% -49.8% -49.6% -49.1% -54.7% -23.0% -31.6% -33.2% -33.3% -36.2% -34.1% -34.13%
ROA -54.3% -65.4% -90.0% -87.1% -76.7% -64.9% -39.5% -38.8% -33.0% -15.6% -27.1% -27.0% -26.7% -29.8% -10.7% -14.7% -15.4% -15.4% -13.1% -12.4% -12.39%
ROIC 19.5% 23.5% -10.7% -10.4% -9.1% -7.7% -4.6% -4.5% -3.8% -1.7% -1.3% -1.3% -1.2% -1.3% -28.8% -40.8% -41.6% -39.1% -28.4% -26.0% -25.97%
ROCE -69.6% -84.3% -1.6% -1.5% -1.4% -1.1% -49.9% -47.9% -39.0% -14.8% -22.9% -21.9% -20.5% -22.2% -5.2% -8.5% -8.8% -8.7% -8.8% -8.5% -8.54%
Gross Margin 1.0% 1.0% 1.0% 81.8% 94.5% 85.3% 92.8% 86.5% 84.4% 86.4% 85.2% 83.6% 86.3% 84.0% 84.3% 83.4% 87.3% 98.8% 90.6% 94.9% 94.91%
Operating Margin -34.1% -36.0% -34.3% -59.4% -10.4% -4.4% 27.5% -2.3% -74.4% 13.1% -81.4% -53.6% -18.6% 2.3% 7.0% -49.0% -14.7% 4.2% 4.1% -34.7% -34.71%
Net Margin -34.4% -37.2% -35.2% -60.0% -10.7% -4.6% 24.2% -2.4% -76.7% 11.8% -83.8% -57.6% -22.5% -0.8% 4.0% -55.5% -19.5% -0.9% -0.3% -39.8% -39.81%
EBITDA Margin -33.2% -35.7% -34.1% -57.4% -10.2% -4.1% 30.6% -2.1% -60.5% 16.2% -73.6% -47.6% -14.9% 5.1% 9.5% -45.1% -12.2% 5.3% 4.8% -33.7% -33.74%
FCF Margin -9.5% -12.2% -15.3% -34.4% -25.7% -13.8% -1.4% -1.4% -85.5% -50.0% -72.4% -51.0% -40.9% -25.3% -13.7% -13.5% -14.3% -13.9% -10.8% -8.8% -8.77%
OCF Margin -9.3% -12.0% -15.1% -34.1% -25.6% -13.7% -1.3% -1.4% -85.3% -49.7% -72.1% -50.7% -40.6% -25.1% -13.4% -13.1% -13.9% -13.5% -10.4% -8.5% -8.48%
ROE 3Y Avg snapshot only -35.08%
ROE 5Y Avg snapshot only -71.51%
ROA 3Y Avg snapshot only -15.34%
ROIC Economic snapshot only -7.99%
Cash ROA snapshot only -7.23%
Cash ROIC snapshot only -31.85%
CROIC snapshot only -32.94%
NOPAT Margin snapshot only -6.91%
Pretax Margin snapshot only -13.55%
R&D / Revenue snapshot only 17.74%
SGA / Revenue snapshot only 83.31%
SBC / Revenue snapshot only 9.02%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -1.52 -0.91 -0.80 -0.92 -0.64 -1.72 -8.22 -15.05 -12.99 -34.99 -21.80 -25.85 -26.68 -22.39 -31.62 -21.79 -16.68 -23.57 -23.06 -25.36 -25.873
P/S Ratio 15.31 12.64 12.56 35.17 16.53 21.81 10.59 15.73 8.79 6.92 11.57 10.69 8.28 6.45 3.71 3.24 2.44 3.35 3.49 3.44 3.529
P/B Ratio 1.51 1.09 1.53 1.70 1.04 2.38 5.62 10.08 7.41 9.46 8.63 10.20 10.42 9.74 7.14 6.76 5.43 7.69 8.51 8.82 10.107
P/FCF -1.61 -1.03 -0.82 -1.02 -0.64 -1.58 -7.83 -11.30 -10.29 -13.86 -15.99 -20.97 -20.25 -25.48 -27.00 -24.04 -17.04 -24.08 -32.30 -39.27 -39.272
P/OCF
EV/EBITDA -0.50 -0.04 -0.37 -0.47 -0.11 -1.16 -7.78 -15.93 -14.44 -57.24 -24.50 -30.50 -32.87 -28.21 -68.25 -38.08 -28.91 -43.51 -40.89 -44.51 -44.506
EV/Revenue 4.75 0.59 5.51 17.30 2.83 13.91 8.92 14.34 7.74 6.27 10.54 9.89 7.67 5.94 3.42 2.97 2.19 3.10 3.36 3.32 3.319
EV/EBIT -0.49 -0.04 -0.36 -0.46 -0.11 -1.14 -7.48 -15.18 -13.22 -45.62 -23.16 -29.01 -31.80 -27.23 -60.75 -35.29 -26.81 -39.80 -37.46 -40.25 -40.251
EV/FCF -0.50 -0.05 -0.36 -0.50 -0.11 -1.01 -6.59 -10.30 -9.05 -12.56 -14.56 -19.39 -18.76 -23.47 -24.89 -22.06 -15.29 -22.34 -31.09 -37.86 -37.856
Earnings Yield -65.9% -1.1% -1.2% -1.1% -1.6% -58.1% -12.2% -6.6% -7.7% -2.9% -4.6% -3.9% -3.7% -4.5% -3.2% -4.6% -6.0% -4.2% -4.3% -3.9% -3.94%
FCF Yield -62.0% -96.7% -1.2% -97.8% -1.6% -63.2% -12.8% -8.9% -9.7% -7.2% -6.3% -4.8% -4.9% -3.9% -3.7% -4.2% -5.9% -4.2% -3.1% -2.5% -2.55%
PEG Ratio snapshot only 2.438
Price/Tangible Book snapshot only 8.821
EV/Gross Profit snapshot only 3.572
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 6.87 6.87 2.53 2.53 2.53 2.53 2.34 2.34 2.34 2.34 4.88 4.88 4.88 4.88 4.58 4.58 4.58 4.58 4.31 4.31 4.315
Quick Ratio 6.87 6.87 2.53 2.53 2.53 2.53 2.29 2.29 2.29 2.29 4.64 4.64 4.64 4.64 4.31 4.31 4.31 4.31 4.11 4.11 4.115
Debt/Equity 0.44 0.44 0.55 0.55 0.55 0.55 0.37 0.37 0.37 0.37 0.34 0.34 0.34 0.34 0.89 0.89 0.89 0.89 1.27 1.27 1.267
Net Debt/Equity -1.04 -1.04 -0.86 -0.86 -0.86 -0.86 -0.89 -0.89 -0.89 -0.89 -0.77 -0.77 -0.77 -0.77 -0.56 -0.56 -0.56 -0.56 -0.32 -0.32 -0.318
Debt/Assets 0.28 0.28 0.30 0.30 0.30 0.30 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.19 0.35 0.35 0.35 0.35 0.42 0.42 0.422
Debt/EBITDA -0.47 -0.38 -0.30 -0.31 -0.35 -0.42 -0.61 -0.64 -0.82 -2.48 -1.05 -1.09 -1.14 -1.06 -9.18 -5.44 -5.26 -5.40 -6.33 -6.63 -6.634
Net Debt/EBITDA 1.10 0.91 0.47 0.48 0.55 0.66 1.46 1.54 1.97 5.94 2.40 2.49 2.62 2.42 5.78 3.42 3.31 3.40 1.59 1.66 1.665
Interest Coverage -25.01 -30.21 -34.13 -35.90 -35.12 -25.96 -12.25 -9.42 -6.40 -2.34 -6.38 -4.96 -3.67 -3.22 -0.93 -1.37 -1.31 -1.27 -1.39 -1.31 -1.313
Equity Multiplier 1.60 1.60 1.81 1.81 1.81 1.81 1.93 1.93 1.93 1.93 1.78 1.78 1.78 1.78 2.51 2.51 2.51 2.51 3.00 3.00 3.005
Cash Ratio snapshot only 2.987
Debt Service Coverage snapshot only -1.187
Cash to Debt snapshot only 1.251
FCF to Debt snapshot only -0.177
Defensive Interval snapshot only 282.5 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.05 0.05 0.06 0.02 0.03 0.05 0.31 0.37 0.49 0.79 0.51 0.65 0.86 1.03 0.91 0.99 1.05 1.09 0.87 0.91 0.913
Inventory Turnover 2.51 3.39 5.44 9.68 2.26 3.03 3.86 4.88 3.07 3.35 3.49 2.63 1.94 1.56 1.558
Receivables Turnover 33.11 29.01 40.23 15.87 20.70 35.89 12.67 15.31 20.13 32.61 8.36 10.69 14.11 16.92 8.37 9.07 9.69 9.99 6.29 6.60 6.602
Payables Turnover 0.26 0.26 0.20 0.02 0.05 0.19 0.54 0.74 1.18 2.10 1.62 2.17 2.76 3.49 3.80 4.15 4.33 3.26 2.15 1.72 1.720
DSO 11 13 9 23 18 10 29 24 18 11 44 34 26 22 44 40 38 37 58 55 55.3 days
DIO 0 0 0 0 0 0 145 108 67 38 161 121 95 75 119 109 105 139 188 234 234.3 days
DPO 1420 1420 1807 21262 8104 1892 671 496 310 174 226 169 132 105 96 88 84 112 170 212 212.2 days
Cash Conversion Cycle -1409 -1408 -1798 -21239 -8087 -1882 -497 -365 -224 -125 -21 -14 -12 -8 67 61 58 63 76 77 77.4 days
Fixed Asset Turnover snapshot only 61.281
Operating Cycle snapshot only 289.6 days
Cash Velocity snapshot only 1.616
Capital Intensity snapshot only 1.173
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 49.4% 35.8% 33.4% -69.2% -58.2% -17.2% 4.2% 14.8% 14.9% 13.9% 1.4% 1.5% 1.5% 87.6% 1.7% 1.3% 83.9% 58.1% 22.1% 18.2% 18.24%
Net Income -38.2% -76.9% -67.7% -45.7% -7.6% 24.3% 57.5% 56.9% 58.4% 76.7% 1.7% 0.1% -16.1% -1.7% 40.8% 18.3% 13.4% 22.1% -57.4% -8.0% -7.99%
EPS -23.1% -51.8% -32.4% -8.1% 26.1% 52.3% 74.7% 72.8% 71.8% 83.1% 18.0% 11.3% -6.4% -1.6% 43.6% 20.2% 15.4% 24.0% -57.7% -4.8% -4.82%
FCF -55.3% -77.0% -88.9% -34.6% -13.6% 6.6% 54.3% 36.0% 47.1% 46.0% -27.6% 7.6% -21.2% 4.9% 49.1% 39.9% 35.7% 13.2% 4.0% 23.0% 23.05%
EBITDA -43.6% -84.8% -74.0% -49.6% -9.0% 25.0% 60.7% 61.5% 65.8% 86.4% 10.4% 9.1% -10.3% -2.6% 68.8% 45.3% 40.4% 46.5% -1.0% -13.0% -12.99%
Op. Income -40.0% -79.0% -70.0% -48.6% -8.1% 24.2% 58.7% 58.7% 60.1% 79.2% 0.8% 0.2% -12.3% -1.8% 55.8% 36.0% 31.4% 40.8% -46.6% 5.6% 5.55%
OCF Growth snapshot only 23.73%
Asset Growth snapshot only 15.11%
Equity Growth snapshot only -3.66%
Debt Growth snapshot only 37.90%
Shares Change snapshot only 3.03%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y -34.6% -37.5% 57.0% 1.4% 1.7% 42.5% 1.1% 1.1% 1.2% 1.6% 1.5% 1.3% 1.6% 1.9% 2.2% 3.5% 3.2% 2.5% 98.4% 89.3% 89.29%
Revenue 5Y 4.4% 7.3% 13.3% 24.7% 1.2% 2.5% 2.8% 1.4% 1.3% 1.2% 1.2% 1.2% 1.2% 1.0% 1.01%
EPS 3Y
EPS 5Y
Net Income 3Y
Net Income 5Y
EBITDA 3Y
EBITDA 5Y
Gross Profit 3Y -31.5% -34.8% 62.0% 1.4% 1.6% 47.4% 1.2% 1.1% 1.1% 1.5% 1.4% 1.3% 1.5% 1.8% 2.1% 3.3% 3.0% 2.5% 97.4% 90.5% 90.49%
Gross Profit 5Y 7.4% 10.1% 15.8% 27.1% 1.2% 2.4% 2.7% 1.4% 1.3% 1.2% 1.1% 1.1% 1.2% 1.0% 1.02%
Op. Income 3Y
Op. Income 5Y
FCF 3Y
FCF 5Y
OCF 3Y
OCF 5Y
Assets 3Y 8.5% 8.5% -6.5% -6.5% -6.5% -6.5% -9.9% -9.9% -9.9% -9.9% 13.9% 13.9% 13.9% 13.9% 42.7% 42.7% 42.7% 42.7% 38.2% 38.2% 38.19%
Assets 5Y 11.5% 11.5% -6.8% -6.8% -6.8% -6.8% 3.8% 3.8% 3.8% 3.8% 10.2% 10.2% 10.2% 10.2% 10.9% 10.9% 10.9% 10.9% 20.0% 20.0% 20.00%
Equity 3Y -3.3% -3.3% -10.6% -10.6% -10.6% -10.6% -19.2% -19.2% -19.2% -19.2% 9.8% 9.8% 9.8% 9.8% 28.0% 28.0% 28.0% 28.0% 19.3% 19.3% 19.30%
Book Value 3Y -21.8% -18.6% -27.3% -30.2% -32.5% -35.3% -42.5% -39.1% -39.8% -40.9% -19.7% -18.0% -17.4% -16.4% -0.3% 4.8% 8.4% 12.7% 10.5% 12.7% 12.65%
Dividend 3Y
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.00 0.00 0.98 0.38 0.46 0.85 0.00 0.01 0.06 0.18 0.67 0.65 0.65 0.69 0.69 0.72 0.77 0.84 0.86 0.88 0.883
Earnings Stability 0.12 0.18 0.30 0.29 0.31 0.28 0.11 0.13 0.06 0.00 0.05 0.11 0.23 0.22 0.36 0.33 0.43 0.32 0.45 0.54 0.544
Margin Stability 0.91 0.90 0.93 0.95 0.96 0.92 0.93 0.93 0.93 0.93 0.93 0.94 0.94 0.95 0.96 0.94 0.95 0.94 0.94 0.96 0.956
Rev. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 1.00 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 0.00 0.00 1.00 1.00 0.50 0.50 0.00 0.00 0.000
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.85 0.50 0.50 0.82 0.97 0.90 0.50 0.50 0.50 0.50 0.99 1.00 0.94 0.50 0.84 0.93 0.95 0.91 0.50 0.97 0.968
Earnings Smoothness
ROE Trend -0.30 -0.52 -1.29 -1.19 -0.89 -0.56 0.65 0.67 0.74 1.02 0.90 0.87 0.71 0.39 0.31 0.22 0.16 0.03 -0.06 0.00 0.005
Gross Margin Trend -0.03 0.01 -0.03 0.07 0.04 -0.05 -0.02 -0.03 -0.05 -0.02 -0.05 -0.09 -0.07 -0.04 -0.04 -0.04 -0.03 0.02 0.06 0.08 0.082
FCF Margin Trend 159.91 6.01 -2.62 -23.95 -16.44 -2.99 11.69 19.74 16.76 12.50 7.60 17.39 12.89 6.89 0.90 0.82 0.49 0.24 0.32 0.23 0.235
Sustainable Growth Rate
Internal Growth Rate
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 0.93 0.87 0.96 0.89 0.99 1.08 1.04 1.32 1.26 2.51 1.36 1.23 1.31 0.87 1.14 0.88 0.95 0.95 0.69 0.62 0.625
FCF/OCF 1.02 1.02 1.01 1.01 1.01 1.00 1.01 1.01 1.00 1.01 1.00 1.01 1.01 1.01 1.02 1.02 1.03 1.03 1.04 1.03 1.034
FCF/Net Income snapshot only 0.646
CapEx/Revenue 14.6% 20.3% 18.5% 27.3% 15.8% 4.2% 1.0% 0.9% 0.2% 0.3% 0.3% 0.3% 0.2% 0.2% 0.3% 0.3% 0.4% 0.4% 0.4% 0.3% 0.29%
CapEx/Depreciation snapshot only 0.367
Accruals Ratio -0.04 -0.09 -0.03 -0.10 -0.01 0.05 0.02 0.13 0.09 0.24 0.10 0.06 0.08 -0.04 0.02 -0.02 -0.01 -0.01 -0.04 -0.05 -0.047
Sloan Accruals snapshot only 0.025
Cash Flow Adequacy snapshot only -29.339
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio
FCF Payout Ratio
Total Payout Ratio
Div. Increase Streak
Chowder Number
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -32.9% -48.9% -79.8% -52.0% -66.6% -44.2% -13.0% -11.7% -15.8% -14.8% -8.3% -4.2% -3.6% -0.5% -0.6% -0.5% -0.5% -0.4% -0.4% -0.7% -0.67%
Total Shareholder Return -32.9% -48.9% -79.8% -52.0% -66.6% -44.2% -13.0% -11.7% -15.8% -14.8% -8.3% -4.2% -3.6% -0.5% -0.6% -0.5% -0.5% -0.4% -0.4% -0.7% -0.67%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.01 1.01 1.01 1.01 1.01 1.01 1.02 1.02 1.02 1.02 1.00 1.002
Interest Burden (EBT/EBIT) 1.04 1.03 1.03 1.03 1.03 1.04 1.08 1.11 1.16 1.43 1.16 1.20 1.27 1.31 2.07 1.73 1.76 1.79 1.66 1.64 1.643
EBIT Margin -9.70 -13.42 -15.22 -37.39 -25.23 -12.20 -1.19 -0.94 -0.59 -0.14 -0.46 -0.34 -0.24 -0.22 -0.06 -0.08 -0.08 -0.08 -0.09 -0.08 -0.082
Asset Turnover 0.05 0.05 0.06 0.02 0.03 0.05 0.31 0.37 0.49 0.79 0.51 0.65 0.86 1.03 0.91 0.99 1.05 1.09 0.87 0.91 0.913
Equity Multiplier 1.48 1.48 1.68 1.68 1.68 1.68 1.88 1.88 1.88 1.88 1.84 1.84 1.84 1.84 2.16 2.16 2.16 2.16 2.76 2.76 2.755
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-1.25 $-1.45 $-1.37 $-1.17 $-0.93 $-0.69 $-0.35 $-0.32 $-0.26 $-0.12 $-0.28 $-0.28 $-0.28 $-0.31 $-0.16 $-0.23 $-0.24 $-0.23 $-0.25 $-0.24 $-0.24
Book Value/Share $1.26 $1.21 $0.72 $0.63 $0.57 $0.50 $0.51 $0.47 $0.46 $0.43 $0.72 $0.72 $0.71 $0.71 $0.71 $0.73 $0.72 $0.72 $0.69 $0.68 $0.60
Tangible Book/Share $1.26 $1.21 $0.72 $0.63 $0.57 $0.50 $0.51 $0.47 $0.46 $0.43 $0.72 $0.72 $0.71 $0.71 $0.71 $0.73 $0.72 $0.72 $0.69 $0.68 $0.68
Revenue/Share $0.12 $0.10 $0.09 $0.03 $0.04 $0.05 $0.27 $0.30 $0.39 $0.59 $0.54 $0.68 $0.90 $1.07 $1.37 $1.52 $1.61 $1.65 $1.67 $1.74 $1.74
FCF/Share $-1.18 $-1.28 $-1.34 $-1.05 $-0.92 $-0.75 $-0.36 $-0.42 $-0.33 $-0.29 $-0.39 $-0.35 $-0.37 $-0.27 $-0.19 $-0.20 $-0.23 $-0.23 $-0.18 $-0.15 $-0.15
OCF/Share $-1.16 $-1.25 $-1.32 $-1.04 $-0.91 $-0.75 $-0.36 $-0.42 $-0.33 $-0.29 $-0.39 $-0.35 $-0.36 $-0.27 $-0.18 $-0.20 $-0.22 $-0.22 $-0.17 $-0.15 $-0.15
Cash/Share $1.86 $1.79 $1.01 $0.89 $0.80 $0.71 $0.64 $0.60 $0.58 $0.54 $0.79 $0.79 $0.79 $0.78 $1.02 $1.05 $1.04 $1.03 $1.09 $1.08 $0.97
EBITDA/Share $-1.19 $-1.39 $-1.32 $-1.13 $-0.89 $-0.66 $-0.31 $-0.27 $-0.21 $-0.06 $-0.23 $-0.22 $-0.21 $-0.22 $-0.07 $-0.12 $-0.12 $-0.12 $-0.14 $-0.13 $-0.13
Debt/Share $0.55 $0.53 $0.39 $0.35 $0.31 $0.28 $0.19 $0.18 $0.17 $0.16 $0.24 $0.24 $0.24 $0.24 $0.63 $0.64 $0.64 $0.63 $0.87 $0.86 $0.86
Net Debt/Share $-1.31 $-1.26 $-0.62 $-0.54 $-0.49 $-0.43 $-0.45 $-0.42 $-0.41 $-0.38 $-0.55 $-0.55 $-0.55 $-0.54 $-0.40 $-0.41 $-0.40 $-0.40 $-0.22 $-0.22 $-0.22
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 1.321
Altman Z-Prime snapshot only 1.835
Piotroski F-Score 3 2 3 1 1 1 3 4 3 4 4 4 5 4 3 4 5 5 5 4 4
Beneish M-Score -4.52 -5.32 -3.50 -6.60 -1.82 0.72 41.47 25.47 12.62 15.03 -0.01 0.47 -0.06 -1.23 -0.24 -1.26 -1.16 -1.12 -2.33 -2.36 -2.356
Ohlson O-Score snapshot only -5.493
ROIC (Greenblatt) snapshot only -11.73%
Net-Net WC snapshot only $0.19
EVA snapshot only $-40948090.00
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only BB-
Credit Score 29.49 29.76 27.10 27.51 27.68 28.09 30.39 36.29 29.97 40.83 58.15 63.74 64.00 63.89 40.44 40.53 35.40 40.16 33.45 37.86 37.857
Credit Grade snapshot only 13
Credit Trend snapshot only -2.668
Implied Spread (bps) snapshot only 550.000
Industry Credit Rank snapshot only 31
Sector Credit Rank snapshot only 29

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms